KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Costar (CSGP) Asset Writedowns and Impairment (2016 - 2025)

Costar (CSGP) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 40.2% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.0 million, a 11.11% decrease, with the full-year FY2025 number at $32.0 million, down 11.11% from a year prior.
  • Asset Writedowns and Impairment was $6.1 million for Q4 2025 at Costar, down from $9.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $11.8 million in Q3 2023 to a low of $1.7 million in Q3 2021.
  • A 5-year average of $6.6 million and a median of $7.0 million in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 70.56% in 2021, then surged 284.45% in 2022.
  • Costar's Asset Writedowns and Impairment stood at $3.1 million in 2021, then skyrocketed by 55.72% to $4.8 million in 2022, then skyrocketed by 92.47% to $9.3 million in 2023, then increased by 9.68% to $10.2 million in 2024, then tumbled by 40.2% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for CSGP's Asset Writedowns and Impairment are $6.1 million (Q4 2025), $9.0 million (Q3 2025), and $7.5 million (Q2 2025).